The dose can be increased to 50-100 mcg for the next two weeks, but only for advanced athletes
Rybelsus is an FDA-approved swallowed semaglutide tablet manufactured by Novo Nordisk and absorbed through the GI tract
Helmstdter J, Frenis K, Filippou K, Grill A, Dib M, Kalinovic S, Pawelke F, Kus K, Krller-Schn S, Oelze M, Chlopicki S, Schuppan D, Wenzel P, Ruf W, Drucker DJ, Mnzel T, Daiber A, Steven S
More than one billion people worldwide are living with obesity, which increases their risk of major health complications, including T2D, high blood pressure, heart disease, stroke, metabolic syndrome, fatty liver diseases, some cancers, kidney disease, breathing problems, and sleep apnea
Long-term safety data in the pediatric population is still limited, and ongoing surveillance is crucial to identify potential long-term effects on growth and development
This question arises as tirzepatide gains attention for its metabolic benefits in type 2 diabetes and weight management